Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy

Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy

Thumbnail Image
Download
Name

Basu-2009-Nanoparticle-mediate.pdf

Size

775 KB

Format

Adobe PDF

Checksum (MD5)

f90cca20cdb1fdd017bec6c4e7abfb6d

Author(s)
Mashelkar, Raghunath Anant
•
Chimote, Geetanjali
•
Soni, Shivani
•
Harfouche, Rania
•
Basu, Kaushik
•
Sengupta, Shiladitya
Date Issued
March 2009
Journal
Proceedings of the National Academy of Sciences of the United States of America
Publisher
United States National Academy of Sciences
Citation
Basu, Sudipta et al. “Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy.” Proceedings of the National Academy of Sciences 106.19 (2009): 7957-7961. © 2009 National Academy of Sciences
Version
Final published version
Abstract
The MAPK signal transduction cascade is dysregulated in a majority of human tumors. Here we report that a nanoparticle-mediated targeting of this pathway can optimize cancer chemotherapy. We engineered nanoparticles from a unique hexadentate-polyD,L-lactic acid-co-glycolic acid polymer chemically conjugated to PD98059, a selective MAPK inhibitor. The nanoparticles are taken up by cancer cells through endocytosis and demonstrate sustained release of the active agent, resulting in the inhibition of phosphorylation of downstream extracellular signal regulated kinase. We demonstrate that nanoparticle-mediated targeting of MAPK inhibits the proliferation of melanoma and lung carcinoma cells and induces apoptosis in vitro. Administration of the PD98059-nanoparticles in melanoma-bearing mice inhibits tumor growth and enhances the antitumor efficacy of cisplatin chemotherapy. Our study shows the nanoparticle-mediated delivery of signal transduction inhibitors can emerge as a unique paradigm in cancer chemotherapy.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/52539
DOI of Published Version
http://dx.doi.org/10.1073/pnas.0902857106
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.